Drug ad violations rising, biologics numbers down

Share this article:
Enforcement trends in recent years between the FDA's Center for Drugs and its Center for Biologics, as measured by numbers of citations for violating advertising/promotion regulations, appear to be on divergent paths—with increased actions being taken against drug advertisers and declining numbers of actions against biologics.

At a recent Food and Drug Law Institute conference, the FDA's DDMAC director Thomas Abrams said possible reasons for the upward trend in his enforcement actions may be more aggressive promotion on the part of drug advertisers, as well as better prioritization of agency resources in order to have greatest impact on public health.

He said a total of 15 Warning Letters were issued in 2005, and 14 such letters in each of the past two years—up from a previous average of four or five annually.

Abrams' Biologics Center counterpart, Ele Ibarra-Pratt, told the meeting that actions against biologics advertisers have gone from a peak of seven untitled letters and six Warning Letters issued in 2004 to two so far this year.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.